IQVIA Report on Stimulant Trends from 2012 - 2023 (PDF) (November 13, 2024)

Buprenorphine Treatment for Substance Use Disorder (PDF) (August 23, 2024)

Trends in Ketamine and Esketamine Dispensing and Administration (PDF) (October 3, 2024)

IQVIA Report on Stimulant Trends from 2012 - 2021 (PDF) (October 31, 2022)

Instructions to request exception to 21 CFR 1306.07(b) 3-day rule (EO-DEA248R1) (PDF) (January 13, 2023)

Advisory - Methadone Hydrochloride Tablets USP 40 mg (Dispersible)

Notice to Registrants Making Payment by Check (March 3, 2003)